Immune Mediator Pharmacogenomics: TCL1A SNPs and Estrogen-Dependent Regulation of Inflammation

Ming-Fen Ho, Richard M. Weinshilboum

Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA


Synergistic Mediation of Sulforaphane and Vitamin D on the Wnt-signaling Pathway

How to cite this article? Here is an example:

 

Ho MF, Weinshilboum RM. Immune Mediator Pharmacogenomics: TCL1A SNPs and Estrogen-Dependent Regulation of Inflammation. J Nat Sci, 3(8):e416, 2017.

 

Click here for more options

 

 

Abstract         Full Text (HTML)           Full Text (PDF)

 

 

 



HomeAbout JNSCI Privacy PolicyPeer ReviewPub Fee
Advertisement FeeAuthor Guidance 

©2017 Journal of Nature and Science (JNSCI), Los Angeles, CA, USA | ISSN 2377-2700 | Contact: editor@jnsci.org